Neeraj Agarwal
The University of Texas MD Anderson Cancer Center(US)Jaypee Institute of Information Technology(IN)SMS Medical College(IN)SUNY Upstate Medical University(US)University of Utah(US)Huntsman Cancer Institute(US)Sawai Man Singh Hospital(IN)Noida International University(IN)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial(2014)1,480 cited
- → External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study(2013)1,008 cited
- → Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial(2016)931 cited
- → Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology(2020)624 cited
- → Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology(2017)577 cited
- → Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium